Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 26, 1996 - Issue 12
Submit an article Journal homepage
44
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Absorption, pharmacokinetics and metabolism of 14C-sumatriptan following intranasal administration to the rat

D. W. Ayres International BioMet Division, GlaxoWellcome Research and Development, Ware, UK, SG12 0DP
,
A. Barrow International BioMet Division, GlaxoWellcome Research and Development, Ware, UK, SG12 0DP
,
N. L. Scully International BioMet Division, GlaxoWellcome Research and Development, Ware, UK, SG12 0DP
,
G. C. Curtis Bio Dynamics Research Ltd, Cardiff Medicentre, The University Hospital of Wales, Cardiff, UK, CF4 4UJ
&
H. M. Hughes Bio Dynamics Research Ltd, Cardiff Medicentre, The University Hospital of Wales, Cardiff, UK, CF4 4UJ
Pages 1273-1282 | Received 30 Apr 1996, Published online: 22 Sep 2008

References

  • Andrew P. D., Birch H. L., Phillpot D. A. Determination of sumatriptan succinate in plasma and urine by high performance liquid chromatography with electrochemical detection. Journal of Pharmaceutical Sciences 1993; 82: 73–76
  • Bateman D. N. Sumatriptan. Lancet 1993; 341: 221–224
  • Char H., Kumar S., Patel S., Piemontese D., Igbal K., Malick A. W., Salvador R. A., Bell C. R. Nasal delivery of [14C]-dextromorphan hydrochloride in rats: levels in plasma and brain. Journal of Pharmaceutical Sciences 1992; 81: 750–752
  • Chien Y. W., Su K. S. E., Chang S. -F. Nasal Systemic Drug Delivery. Marcel Dekker, New York 1989
  • Dixon C. M., Saynor D. A., Andrew P. D., Oxford J. M., Bradbury A., Tarbit M. H. Disposition of sumatriptan in laboratory animals and humans. Drug Metabolism and Disposition 1993; 21: 761–769
  • Dixon C. M., Park G. R., Tarbit M. H. Characterisation of the enzyme responsible for the metabolism of sumatriptan in human liver. Biochemical Pharmacology 1994; 47: 1253–1256
  • Duchateau G. S. M. J. E., Zuidema J., Albers W. M., Merkus F. W. H. M. Nasal absorption of alprenolol and metoprolol. International Journal of Pharmaceutics 1986; 34: 131–136
  • Fisher A. N., Brown K., Davis S. S., Parr G. D., Smith D. A. The effect of molecular size on the nasal absorption of water-soluble compounds in the albino rat. Journal of Pharmacy and Pharmacology 1986; 39: 357–362
  • Fowler P. A., Fuseau E., Chilton J., Hussey E. K., Moore K. P. The clinical pharmacology of sumatriptan nasal spray. Cephalalagia 1995; 15: S14–238
  • Hirai S., Yashiki T., Matsuzawa T., Mima H. Absorption of drugs from the nasal mucosa of rat. International Journal of Pharmaceutics 1981; 7: 317–325
  • Huang C. H., Kimura R., Nassar R. B., Hussain A. Mechanism of nasal absorption of drugs 1. Physiochemical parameters influencing the rate of in situ nasal absorption of drugs in rats. Journal of Pharmaceutical Sciences 1985; 74: 608–611
  • Lacey L. F., Keene O. N., Duquesnoy C., Bye A. Evaluation of different indirect measure of rate of absorption in comparative pharmacokinetic studies. Journal of Pharmaceutical Sciences 1994; 83: 212–215
  • Lacey L. F., Hussey E. K., Fowler P. A. Single dose pharmacokinetics of sumatriptan. European Journal of Clinical Pharmacology 1995; 47: 543–548
  • McMartin C., Hutchinson L. E. F., Hyde R., Peters G. E. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. Journal of Pharmaceutical Sciences 1987; 76: 535–540
  • Pujara C. P., Shao Z., Duncan M. R., Mitra A. K. Effects of formulation variables on nasal epithehial cell integrity: biochemical evaluations. International Journal of Pharmaceutics 1995; 114: 197–203
  • Reed C. J. Drug metabolism in the nasal cavity: relevance to toxicology. Drug Metabolism Reviews 1993; 25: 173–205
  • Sarker M. A. Drug Metabolism in the nasal mucosa. Pharmaceutical Research 1992; 9: 1–9
  • Scott A. K. Sumatriptan: clinical pharmacokinetics. Clinical Pharmacokinetics 1994; 27: 337–344
  • Su K. S. E., Campanale K. M., Gries C. L. Nasal drug delivery system of a quaternary ammonium compound: clofilium tosylate. Journal of Pharmaceutical Sciences 1984; 73: 1251–1254

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.